A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Patients With Unstable Angina Not Responding to Standard Medical Therapy Who Are Eligible for Coronary Angioplasty

PHASE3CompletedINTERVENTIONAL

Enrollment

1,265

Participants

Timeline

Start Date

May 31, 1993

Primary Completion Date

December 31, 1995

Study Completion Date

December 31, 1995

Conditions

Angina, UnstableAngioplasty, Transluminal, Percutaneous Coronary

Interventions

DRUG

Abciximab

DRUG

Placebo